Tech investors take a Warren Buffett approach to raising money for blood cancer research

Venture capitalist David Lee was diagnosed with Hodgkin’s lymphoma 24 years ago when he was a graduate Student at Stanford. Rhett Krawitt’s acute lymphoblastic leukemia was discovered eight years ago when he was just a toddler. Both are now cancer-free. Lee has a thriving investment career in Los Angeles and Krawitt is a Bay Area […]

In the next few weeks, you can spend time with any one of these VCs and it will all go to charity

Five years ago, we told you about a venture capital auction wherein dozens of VCs donated their time toward a greater good — helping fund research at the Leukemia & Lymphoma Society, one of the world’s largest voluntary health organizations dedicated to funding research and access to treatments for blood cancer patients. The auction was […]

Here’s the Problem with Today’s Human Clinical Trials

LAGUNA NIGUEL, Calif.—The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials. They’re necessary, from a regulatory standpoint as well as an intellectual one. And of course […]